Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net income	$ 231,075,000	$ 167,906,000
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	17,437,000	11,019,000
Stock-based compensation expense	18,095,000	26,517,000
Fair value of mortgage loans held for sale and other	(647,000)	(2,269,000)
Inventory impairment	1,942,000	0
Impairment on other investment	7,722,000
Abandonment of lot option contracts	3,941,000	3,021,000
Deferred income taxes	(243,000)	2,078,000
(Gain) loss on disposition of assets	(1,851,000)	1,062,000
Changes in assets and liabilities:
Cash held in escrow	31,090,000	4,081,000
Accounts receivable	3,802,000	(1,081,000)
Inventories	(421,938,000)	(225,587,000)
Mortgage loans held for sale	(9,387,000)	36,343,000
Prepaid expenses and other assets	(50,041,000)	(21,179,000)
Accounts payable	14,659,000	54,126,000
Accrued expenses and other liabilities	(19,639,000)	(23,029,000)
Net cash (used in) provided by operating activities	(173,983,000)	33,008,000
Investing activities
Purchases of property and equipment	(29,856,000)	(14,565,000)
Proceeds from sale of property and equipment	11,169,000	127,000
Expenditures related to development of rental properties	(98,029,000)	(59,812,000)
Business combinations	(157,130,000)
Other investing activities	(3,860,000)	(346,000)
Net cash used in investing activities	(277,706,000)	(74,596,000)
Financing activities
Borrowings under revolving credit facilities	1,459,000,000	25,000,000
Payments on revolving credit facilities	(1,045,000,000)	(25,000,000)
Borrowing under construction loan agreements	65,442,000	21,453,000
Proceeds from issuance of insurance premium notes and other	19,619,000	26,511,000
Principal payments on insurance premium notes and other	(29,779,000)	(17,273,000)
Net proceeds (payments) for mortgage repurchase facilities	7,916,000	(35,532,000)
Withholding of common stock upon vesting of stock-based compensation awards	(10,473,000)	(10,672,000)
Repurchases of common stock under stock repurchase program	(53,139,000)	(19,227,000)
Dividend payments	(24,629,000)	(22,074,000)
Other financing activities	(363,000)
Net cash provided by (used in) financing activities	388,594,000	(56,814,000)
Net decrease	(63,095,000)	(98,402,000)
Cash and cash equivalents and Restricted cash, Beginning of period	242,003,000	308,492,000
Cash and cash equivalents and Restricted cash, End of period	178,908,000	210,090,000
Supplemental cash flow disclosure
Cash paid for income taxes	80,361,000	41,358,000
Cash and cash equivalents and Restricted cash
Cash and cash equivalents	149,155,000	193,111,000
Restricted cash (Note 6)	29,753,000	16,979,000
Cash and cash equivalents and Restricted cash	$ 178,908,000	$ 210,090,000